Sonia Shah, MD
Cardiovascular Disease (Cardiology) · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 11
Offices
11 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shah’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A150922 · Current
Licensed to practise in California · since 2017 · expires 2027-08-31 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$173,145
Medicare paid this office $173,145 for 842 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 332 | $43,864 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $19,099 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $18,079 | $102 |
| Long return visit (40+ min) | 102 | $17,479 | $149 |
| New patient visit (45+ min) | 98 | $13,875 | $142 |
See all 25 services
| Return visit (30+ min) | 332 | $43,864 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $19,099 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $18,079 | $102 |
| Long return visit (40+ min) | 102 | $17,479 | $149 |
| New patient visit (45+ min) | 98 | $13,875 | $142 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $8,533 | $164 |
| Critical care, first 30-74 minutes | 34 | $8,347 | $178 |
| Ultrasound of heart with probe in esophagus, with report | 63 | $5,847 | $91 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $5,748 | $213 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 264 | $4,511 | $15 |
| External shock to heart to regulate heart beat | 42 | $4,194 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,836 | $57 |
| New patient visit (60+ min) | 23 | $3,813 | $166 |
| Short return visit (20+ min) | 20 | $1,571 | $79 |
| 3d radiographic procedure with computerized image postprocessing | 42 | $1,401 | $33 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,268 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $657 | $24 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $654 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $537 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 36 | $374 | $10 |
| Ultrasound of heart, follow-up | 14 | $328 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $251 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $192 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 49 | $138 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $128 | $7 |
Who their Medicare patients are
842 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 28% · Women 53% · Also on Medicaid 10% · Health risk score 1.75. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Atrial fibrillation 48% · Heart failure 42% · Chronic kidney disease 39% · Diabetes 37% · COPD 19% · Cancer 18% · Depression 18% · Stroke 13% · Dementia 11%.
The office billed $771,458, Medicare allowed $235,625 and paid $173,145; for 1,969 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 842 | 1,969 | 79 | 1.75 | $771,458 | $173,145 |
| 2023 | 821 | 1,772 | 79 | 1.62 | $731,450 | $170,346 |
| 2022 | 107 | 183 | 78 | 1.35 | $84,386 | $20,988 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Long return visit (40+ min) | 180 | $32,951 | $146 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $28,169 | $190 |
| Return visit (30+ min) | 232 | $27,155 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $15,910 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $15,485 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $7,144 | $61 |
| New patient visit (45+ min) | 52 | $7,010 | $135 |
| Critical care, first 30-74 minutes | 23 | $5,309 | $177 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $4,505 | $215 |
| New patient visit (60+ min) | 24 | $4,478 | $187 |
| External shock to heart to regulate heart beat | 50 | $4,361 | $86 |
| Ultrasound of heart with probe in esophagus, with report | 43 | $4,248 | $92 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,689 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 113 | $1,447 | $12 |
| 3d radiographic procedure with computerized image postprocessing | 23 | $777 | $34 |
| Ultrasound of heart, follow-up | 29 | $662 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 72 | $618 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 23 | $529 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $450 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $441 | $26 |
| Heart rhythm recording of continous external ekg over 8-15 days | 23 | $297 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $264 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $254 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $131 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $96 | $3 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,231 | $83 |
| New patient visit (60+ min) | 13 | $2,628 | $202 |
| New patient visit (45+ min) | 14 | $2,145 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,080 | $173 |
| Long return visit (40+ min) | 12 | $2,000 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $992 | $62 |
Medicaid work
$4,353 in 2024
Medicaid paid $4,353 for 96 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 23 | $1,855 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $1,140 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $893 |
| Return visit (30+ min) | 26 | $464 |
| 2024 | 96 | 4 | 22 | $4,353 |
| 2023 | 89 | 2 | 18 | $4,108 |
| 2022 | 14 | 1 | 12 | $1,160 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 50 | $3,016 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 39 | $1,092 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $1,160 |
Drugs they prescribed that Part D paid
$929,923
Pharmacies billed $929,923 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,807) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,118 generic and 689 brand-name prescriptions · $929,923 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 296 | $433,580 | $1,465 |
| Entresto | 97 | $105,711 | $1,090 |
| Xarelto | 45 | $73,847 | $1,641 |
| Jardiance | 58 | $73,421 | $1,266 |
| Repatha Sureclick | 53 | $61,259 | $1,156 |
See all 47 drugs
| Eliquis | 296 | $433,580 | $1,465 |
| Entresto | 97 | $105,711 | $1,090 |
| Xarelto | 45 | $73,847 | $1,641 |
| Jardiance | 58 | $73,421 | $1,266 |
| Repatha Sureclick | 53 | $61,259 | $1,156 |
| Ozempic | 18 | $25,958 | $1,442 |
| Praluent | 19 | $18,027 | $949 |
| Farxiga | 15 | $16,505 | $1,100 |
| Atorvastatin | 618 | $10,405 | $17 |
| Rosuvastatin | 339 | $8,595 | $25 |
| Metoprolol | 395 | $6,355 | $16 |
| Ezetimibe | 163 | $5,137 | $32 |
| Dabigatran Etexilate | 12 | $4,122 | $343 |
| Losartan | 251 | $2,997 | $12 |
| Diltiazem 24hr Er (Cd) | 96 | $2,887 | $30 |
| Carvedilol | 205 | $2,649 | $13 |
| Amlodipine Besylate | 297 | $2,490 | $8 |
| Amiodarone | 38 | $2,367 | $62 |
| Irbesartan | 97 | $2,296 | $24 |
| Furosemide | 308 | $1,894 | $6 |
| Valsartan | 48 | $1,656 | $35 |
| Clopidogrel | 82 | $1,520 | $19 |
| Spironolactone | 124 | $1,446 | $12 |
| Isosorbide Mononitrate Er | 46 | $1,273 | $28 |
| Nebivolol | 28 | $1,261 | $45 |
| Hydralazine | 90 | $1,256 | $14 |
| Valsartan-Hydrochlorothiazide | 15 | $1,136 | $76 |
| Torsemide | 35 | $954 | $27 |
| Bisoprolol | 32 | $904 | $28 |
| Losartan-Hydrochlorothiazide | 34 | $869 | $26 |
| Lisinopril | 110 | $745 | $7 |
| Flecainide Acetate | 14 | $640 | $46 |
| Spironolactone-Hctz | 16 | $532 | $33 |
| Metoprolol | 105 | $496 | $5 |
| Olmesartan Medoxomil | 28 | $485 | $17 |
| Pravastatin | 39 | $445 | $11 |
| Diltiazem | 20 | $403 | $20 |
| Hydrochlorothiazide | 106 | $356 | $3 |
| Chlorthalidone | 22 | $305 | $14 |
| Verapamil Er | 13 | $277 | $21 |
| Potassium Chloride | 28 | $258 | $9 |
| Pantoprazole | 11 | $201 | $18 |
| Nitroglycerin | 19 | $190 | $10 |
| Benazepril | 22 | $140 | $6 |
| Triamterene-Hydrochlorothiazid | 15 | $120 | $8 |
| Simvastatin | 14 | $81 | $6 |
| Atenolol | 13 | $69 | $5 |
Year by year
| 2024 | 4,807 | 711 | 0% (0) | 14% | $929,923 |
| 2023 | 2,529 | 517 | 0% (0) | 15% | $542,077 |
| 2022 | 183 | 52 | 0% (0) | 22% | $38,677 |
| 2021 | 107 | 25 | 0% (0) | 25% | $22,390 |
| 2019 | 12 | None | 0% (0) | None | $4,096 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Eliquis | 148 | $203,281 | $1,374 |
| Jardiance | 40 | $55,664 | $1,392 |
| Entresto | 38 | $45,030 | $1,185 |
| Xarelto | 28 | $43,684 | $1,560 |
| Farxiga | 16 | $27,422 | $1,714 |
| Repatha Sureclick | 19 | $23,996 | $1,263 |
| Trulicity | 11 | $22,577 | $2,052 |
| Ozempic | 11 | $17,403 | $1,582 |
| Rosuvastatin | 181 | $7,715 | $43 |
| Metoprolol | 209 | $5,445 | $26 |
| Atorvastatin | 298 | $5,130 | $17 |
| Ezetimibe | 50 | $2,649 | $53 |
| Amlodipine Besylate | 190 | $2,484 | $13 |
| Irbesartan | 53 | $2,341 | $44 |
| Losartan | 114 | $1,829 | $16 |
| Carvedilol | 111 | $1,599 | $14 |
| Furosemide | 159 | $1,406 | $9 |
| Diltiazem 24hr Er (Cd) | 37 | $1,374 | $37 |
| Spironolactone | 90 | $1,340 | $15 |
| Valsartan | 18 | $1,316 | $73 |
| Hydralazine | 57 | $1,135 | $20 |
| Amiodarone | 24 | $872 | $36 |
| Lisinopril | 63 | $846 | $13 |
| Bisoprolol | 19 | $805 | $42 |
| Torsemide | 23 | $762 | $33 |
| Isosorbide Mononitrate Er | 21 | $748 | $36 |
| Clopidogrel | 31 | $742 | $24 |
| Losartan-Hydrochlorothiazide | 23 | $651 | $28 |
| Spironolactone-Hctz | 14 | $532 | $38 |
| Chlorthalidone | 25 | $507 | $20 |
| Potassium Chloride | 16 | $448 | $28 |
| Olmesartan Medoxomil | 12 | $443 | $37 |
| Metoprolol | 45 | $303 | $7 |
| Hydrochlorothiazide | 54 | $221 | $4 |
| Pravastatin | 11 | $181 | $16 |
| Nitroglycerin | 12 | $171 | $14 |
| Atenolol | 11 | $84 | $8 |
2022: 6 drugs
| Jardiance | 15 | $20,476 | $1,365 |
| Atorvastatin | 24 | $340 | $14 |
| Carvedilol | 12 | $181 | $15 |
| Spironolactone | 13 | $163 | $13 |
| Metoprolol | 12 | $142 | $12 |
| Losartan | 16 | $82 | $5 |
2021: 1 drug
| Entresto | 15 | $9,290 | $619 |
Money from drug and device companies
$343 in 2025
| 2025 | 1 | 1 | None | $343 |
| 2024 | 3 | 3 | None | $161 |
| 2022 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $343 | 1 payment
|
See the published payment
| Heartflow | Meals · 2025-06-26 | Ffrct | $343 |
See earlier years (2024, 2022)
2024: $161
| Boston Scientific | Watchman Flx | $103 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $30 | 1 payment
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $28 | 1 payment
|
2022: $18
| AstraZeneca Pharmaceuticals LP | Farxiga | $18 | 1 payment
|
Professional record
- NPI
- 1871982744
- Licence
- CA A150922California A150922: Current · expires 2027-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-01-15
- NPI last updated
- 2022-10-13
- NPI record certified
- 2022-10-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305